NCT02714205 - Flushing Reduction Associated With Nitrates | Biotech Hunter

Enrollment

141

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

March 8, 2022

Study Completion Date

April 5, 2022

Conditions

Menopausal Hot Flashes

Interventions

DRUG

transdermal nitroglycerin

Study participants will be randomized to transdermal nitroglycerin patch or placebo patch. Participants will wear a study medication patch daily, for 12 weeks.

DRUG

Placebo

Study participants will be randomized to transdermal nitroglycerin patch or placebo patch. Participants will wear a study medication patch daily, for 12 weeks.

Trial Locations (2)

94115

University of California, San Francisco, San Francisco

94612

University of California, San Francisco, Oakland

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

Alison Huang, MD

OTHER